How to evaluate a litigation funder

The litigation funding market has matured considerably, but the criteria most practitioners use to evaluate a litigation funder have not kept pace with that maturity. Too many law firms and commercial parties approach funder selection as though it were a straightforward procurement exercise: gather a few term sheets, compare headline multiples, and choose the lowest cost of capital. That approach misses most of what actually determines whether a funding relationship succeeds or fails. A litigation funder is not a passive cheque-writer. It is an active participant in the life of a case, with its own investment thesis, risk appetite, internal governance processes, and exit constraints. Understanding those dimensions is not optional due diligence. It is the foundation of any sound evaluation.

This essay sets out a structured way to think about funder evaluation, covering the misconceptions that distort most initial assessments, the operational realities that sit beneath the surface of any term sheet, the commercial consequences of getting the selection wrong, and the direction the market is likely to move as institutional scrutiny of the asset class intensifies. The goal is to give practitioners and commercial operators a more complete picture of what they are actually choosing when they select a funder, and why that choice deserves more rigour than it typically receives.

What the market usually gets wrong

The dominant misconception in funder evaluation is that the primary variable is price. Practitioners focus heavily on the funding multiple or the funder's share of proceeds, treating those figures as the central basis for comparison. This is understandable. Multiples are legible, comparable across term sheets, and easy to present to a client or board. But they are also deeply incomplete as a basis for decision-making.

Price matters, but it is downstream of a more important question: will this funder behave as a constructive partner throughout the life of the case, including when the case becomes difficult? Litigation is inherently uncertain. Cases that look strong at the point of funding can deteriorate through adverse disclosure, unexpected witness evidence, or shifts in judicial interpretation. The question is not merely what a funder charges when things go well. It is what a funder does when things go badly.

A second common error is treating all funders as structurally equivalent. The litigation funding market contains a wide range of participants, from large institutional platforms with diversified portfolios and dedicated legal teams to smaller vehicles with concentrated exposure and limited operational infrastructure. These are not interchangeable. A funder with a concentrated portfolio has materially different incentives around case management, settlement, and duration than one managing a broad book of cases. A funder backed by patient capital has different exit pressures than one operating under a fixed-term fund structure approaching its end of life. These structural differences shape funder behaviour in ways that are not visible on a term sheet but are highly visible once a case is in flight.

The third error is insufficient attention to governance. Funders make investment decisions through internal committees, and those committees have their own risk tolerances, approval thresholds, and review triggers. A funder that requires committee sign-off on every material procedural step introduces latency into case management that can be operationally damaging. Understanding how a funder's internal governance works, and how quickly it can respond to developments in live litigation, is a practical necessity rather than a theoretical concern.

What actually changes when you look at the operating layer

Once you move past the term sheet and examine how a funder actually operates, several things become visible that are invisible in a purely commercial comparison.

The first is portfolio construction. Sophisticated funders manage their exposure across a portfolio, and that portfolio logic shapes how they think about any individual case. A funder that is already heavily exposed to a particular sector, jurisdiction, or legal theory may price or structure a case differently than one with no existing exposure in that area. Conversely, a funder building out a particular vertical may be willing to accept terms that a more diversified platform would not. Understanding where a case sits in a funder's portfolio context gives you real leverage in negotiation and real insight into how the funder is likely to behave as the case develops.

The second is the quality and accessibility of the funder's legal team. Most institutional funders employ in-house lawyers who conduct due diligence and monitor live investments. The quality of that team, and the degree to which they are genuinely engaged with the case rather than simply tracking milestones, has a direct bearing on the quality of the funding relationship. A funder whose legal team understands the substantive law and procedural landscape of the case is a more useful partner than one whose monitoring is purely financial. This is not a soft consideration. It affects the speed and quality of decisions at critical junctures.

The third is the funder's approach to adverse developments. Every funding agreement contains provisions addressing what happens if the case weakens materially, but those provisions are only part of the picture. The more important question is how the funder behaves in practice when a case faces difficulty. Does it engage constructively with revised strategy? Does it support reasonable settlement discussions? Or does it apply pressure in ways that are not aligned with the claimant's interests? This is difficult to assess from documentation alone, which is why reference-checking with law firms and parties who have worked with a funder in live cases is an essential part of any serious evaluation.

The fourth is duration alignment. Litigation can take years, and the funder's capital structure needs to be able to accommodate that reality. A funder operating under a fund vehicle with a defined end date has structural pressure to realise returns within a particular window. That pressure can manifest as settlement pressure at inopportune moments, or as reluctance to fund appeals or enforcement proceedings that extend the case beyond the fund's natural horizon. Understanding a funder's capital structure and its implications for duration tolerance is a fundamental piece of due diligence that is frequently overlooked.

Commercial consequences

The consequences of poor funder selection are not abstract. They are felt in the day-to-day management of cases and in the outcomes achieved for clients.

The most direct consequence is misaligned incentives at settlement. A funder that is under capital pressure, or that has a different view of risk than the legal team, may push for settlement at a level that does not reflect the case's full value. Because the funder's consent is typically required for settlement under the terms of most funding agreements, a misaligned funder has real leverage at precisely the moment when that leverage is most damaging. This is not a hypothetical risk. It is a documented feature of funding relationships that have not been structured or selected carefully.

A second consequence is reputational exposure for the law firm. Funders are increasingly visible participants in litigation, and the quality of a funder's conduct reflects on the firms and parties associated with it. A funder that behaves aggressively, that is subject to regulatory scrutiny, or that has a poor reputation in the market creates reputational risk for its counterparties. Law firms that are serious about their standing in the litigation finance market need to be selective about the funders they work with, not merely the terms they accept.

A third consequence is the risk of funding withdrawal at a critical stage. Most funding agreements contain provisions allowing the funder to withdraw in defined circumstances, and those provisions are not always as narrow as they appear on first reading. A funder that loses confidence in a case, or that faces its own capital constraints, may seek to exercise withdrawal rights in ways that leave the funded party in a very difficult position. The risk of mid-case withdrawal is not eliminated by careful drafting, but it is substantially reduced by careful funder selection at the outset.

For a broader view of how litigation finance operates as a commercial discipline, the litigation finance section of this site sets out the structural context within which these evaluation decisions sit.

Where the market is likely to move next

The litigation funding market is under increasing scrutiny from regulators, courts, and institutional investors, and that scrutiny is reshaping what good funder evaluation looks like.

Regulatory developments in multiple jurisdictions are moving towards greater disclosure of funding arrangements and, in some cases, direct regulation of funders themselves. This has two implications for evaluation. First, funders that have invested in compliance infrastructure and governance are better placed to operate in a more regulated environment than those that have not. Second, the terms of funding agreements are increasingly subject to judicial review, which means that agreements that are poorly structured or that contain provisions courts find objectionable create real legal risk for all parties. Evaluating a funder's regulatory posture and the quality of its standard documentation is therefore not merely a compliance exercise. It is a risk management necessity.

Institutional capital is also becoming more discerning about the litigation funding asset class. As more pension funds, sovereign wealth vehicles, and insurance-linked capital enters the market, the standards applied to funder governance, reporting, and conduct are rising. Funders that can demonstrate institutional-grade infrastructure are attracting capital on better terms and building more durable franchises. For law firms and commercial parties, this means that the gap between the best and worst funders in the market is widening, and the importance of distinguishing between them is increasing accordingly.

There is also a growing body of market experience about what good funding relationships look like in practice. The market is old enough now that practitioners can draw on real case histories, not just theoretical frameworks, when evaluating funders. That experience is increasingly being shared through professional networks, industry bodies, and published commentary. Practitioners who engage with that body of knowledge are better equipped to make sound evaluation decisions than those who rely solely on the documentation in front of them.

For further reading on the structural and commercial dimensions of litigation finance, the writing section of this site contains related analysis on funding structures, risk allocation, and market development.

What this means in practice

Evaluating a litigation funder well requires a different kind of attention than evaluating most other commercial counterparties. The formal documentation matters, but it is not sufficient. The funder's portfolio logic, capital structure, internal governance, legal team quality, and track record in difficult cases all bear directly on whether the funding relationship will serve the claimant's interests across the full arc of the litigation.

The practical starting point is to treat funder evaluation as a structured process rather than a reactive one. That means developing a consistent set of questions to put to every funder under consideration, seeking references from law firms and parties who have worked with each funder in live cases, and taking the time to understand the funder's capital structure and its implications for duration and settlement behaviour.

It also means being willing to walk away from terms that look attractive on paper if the funder's operating profile raises concerns. A lower multiple from a funder with misaligned incentives or poor governance is not a better deal. It is a different kind of risk, one that is harder to quantify but no less real.

The litigation funding market offers genuine value to parties who use it well. Accessing that value requires treating funder selection with the same rigour that is applied to every other material decision in the life of a case. For practitioners who want to engage further with the principles underlying this analysis, the about page sets out the perspective from which this work is produced, and the contact page is available for direct enquiries.

The market has matured. The evaluation frameworks applied to it should mature accordingly.